Clinical trial

Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)

NCT03510325

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-02-12

PhasePHASE3

Study timeline

Study start (actual)2019-02-12Date precision: day

Registry last updated2025-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Phase 1: OlanzapineDRUG

Phase 1: RisperidoneDRUG

Phase 1: AmisulprideDRUG

Phase 1: AripiprazoleDRUG

Phase 1: PerphenazineDRUG

Phase 2: OlanzapineDRUG

Phase 2: AmisulprideDRUG

Phase 2: ClozapineDRUG

Phase 3A: Clozapine extended treatment or Combined clozapine-MECT therapyOTHER

Phase 3B: Clozapine or another SGAsDRUG

Sponsors & collaborators

Shanghai Mental Health Centerlead sponsor

Mapped research locations

BeijingBeijing Municipality, China1 ShanghaiShanghai Municipality, China1 HangzhouZhejiang, China1 NanjingJiangsu, China1 WuhanHubei, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03510325 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.